Institutional Investors Are Crazy For RPX Corp (NASDAQ:RPXC)

May 18, 2018 - By sdfsdfsdf

RPX Corporation (NASDAQ:RPXC) Logo

Sentiment for RPX Corp (NASDAQ:RPXC)

RPX Corp (NASDAQ:RPXC) institutional sentiment increased to 1.34 in Q4 2017. Its up 0.11, from 1.23 in 2017Q3. The ratio has improved, as 78 investment managers increased or opened new holdings, while 58 cut down and sold holdings in RPX Corp. The investment managers in our partner’s database now possess: 42.83 million shares, down from 42.91 million shares in 2017Q3. Also, the number of investment managers holding RPX Corp in their top 10 holdings was flat from 0 to 0 for the same number . Sold All: 11 Reduced: 47 Increased: 48 New Position: 30.

RPX Corporation provides patent risk management and discovery services in the United States, Japan, South Korea, and internationally. The company has market cap of $521.31 million. It offers a subscription patent risk management service that facilitates exchanges of value between owners and users of patents. It currently has negative earnings. The firm also provides a defensive patent aggregation in which it acquires patent assets to offer clients with sub-licenses; and underwrites patent infringement liability insurance policies to insure against certain costs of litigation.

It closed at $10.44 lastly. It is up 12.13% since May 18, 2017 and is downtrending. It has underperformed by 23.68% the S&P500.

S&T Bank Pa holds 1.4% of its portfolio in RPX Corporation for 616,527 shares. Hays Advisory Llc owns 167,446 shares or 0.8% of their US portfolio. Moreover, Clark Estates Inc Ny has 0.51% invested in the company for 229,000 shares. The New York-based Lucus Advisors Llc has invested 0.48% in the stock. Matarin Capital Management Llc, a Connecticut-based fund reported 396,551 shares.

Since January 1, 0001, it had 0 insider purchases, and 2 sales for $129,418 activity.

RPX Corporation (NASDAQ:RPXC) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.